Suchergebnisse - (Subject:"Prednisone")

PubPharm (10.120)

1

The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study

enthalten in: British journal of haematology | 2024

von Pedersen, M. | Gormsen, L. | Jakobsen, L. | +9

2

Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma : A case report

enthalten in: Medicine | 2024

von Guo, Y. | Li, J. | Li, M. | +7

3

Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma : Results from a multicenter experience

enthalten in: Hematological oncology | 2024

von Zilioli, V. | Cencini, E. | Lorenzo, S. | +7

4

Venetoclax plus dose-adjusted R-EPOCH (VR-DA-EPOCH) or G-EPOCH bridging to subsequent cellular therapy for the patients with transformed lymphoma a single center clinical experience

enthalten in: Annals of hematology | 2024

von Qin, S. | Jiang, R. | Dai, L. | +11

5

New standards of care for treatment of diffuse large B-cell lymphoma

enthalten in: British journal of haematology | 2024

von Abeyakoon, C. | Gregory, G.

6

Analyzing the risk factors for disease progression within 2 years and histological transformation in patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone as first-line treatment : A 15-year follow-up of patients with advanced follicular lymphoma in JCOG0203

enthalten in: Hematological oncology | 2024

von Watanabe, T. | Matsuno, Y. | Wakabayashi, M. | +13

7

Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy

enthalten in: Cancer medicine | 2024

von Sineshaw, H. | Zettler, C. | Prescott, J. | +7

8

The prognostic value of bone marrow retention index and bone marrow-to-liver ratio of baseline 18F-FDG PET/CT in diffuse large B-cell lymphoma

enthalten in: European radiology | 2024

von El-Azony, A. | Basha, M. | Almalki, Y. | +18

9

A phase 1-2 trial of DA-EPOCH-R plus ixazomib for MYC-aberrant lymphoid malignancies : the DACIPHOR regimen

enthalten in: Blood advances | 2024

von Karmali, R. | Galvez, C. | Hamadani, M. | +14

10

A phase II Japanese trial of 90-minute rituximab infusion for untreated B-cell lymphoma

enthalten in: Japanese journal of clinical oncology | 2024

von Saito, T. | Nagai, H. | Izutsu, K. | +7

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1012]